October 31, 2014

Plan Now for Future Ebola Outbreaks

Diagnostics, vaccines and new drugs could vastly improve the way future Ebola outbreaks manifest in Africa, according to emerging infectious disease expert Jeremy Farrar. Steve Mirsky reports

By Steve Mirsky

SUBSCRIBE TO 60-Second Health

Apple | Spotify | RSS

Join Our Community of Science Lovers!

On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.

“Classic public health, isolation and respect and dignity for the people infected, and respect and dignity if individuals do die that they’re buried in appropriate manner, is absolutely critical to bringing this epidemic under control.”

Jeremy Farrar is an emerging infectious disease expert and the director of the Wellcome Trust, a global charitable health foundation. He talked about the current Ebola epidemic in west Africa during a conference call webcast produced by the New England Journal of Medicine on October 22^nd.

“The society where these epidemics are occurring are ultimately going to be critical to bringing the epidemic under control.

“I believe in the 21st century, the classic public health measures that are critical can be complemented by the addition of rapid diagnostics; by the development of vaccines, assessment of safety and efficacy and then deployment; and by the development of drugs. The drugs themselves may not change the epidemic curve, but they may change the relationship the health care facilities and workers have with the community.

“If you offer hope to a previously untreated infection, you will change the way that people present, you will remove some of the stigma and you will be able to demonstrate that people can survive from Ebola. And I believe that is absolutely critical. Being a young doctor during the early stages of HIV in western Europe, it was amazing the change that occurred both in lives, but also in attitudes toward HIV, when we developed antiretroviral drugs.”

To listen to the entire 84-minute New England Journal of Medicine discussion, which also includes Paul Farmer of Partners in Health and Matthew Arduino from the CDC, just go to the Web site of the New England Journal of Medicine and find their special page on the Ebola outbreak. It’s www.nejm.org/page/ebola-outbreak

—Steve Mirsky

[The above text is a transcript of this podcast.]

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American